Online citations, reference lists, and bibliographies.
← Back to Search

Magnetic Nanoparticles For Theragnostics.

V. Shubayev, T. R. Pisanic, S. Jin
Published 2009 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Engineered magnetic nanoparticles (MNPs) represent a cutting-edge tool in medicine because they can be simultaneously functionalized and guided by a magnetic field. Use of MNPs has advanced magnetic resonance imaging (MRI), guided drug and gene delivery, magnetic hyperthermia cancer therapy, tissue engineering, cell tracking and bioseparation. Integrative therapeutic and diagnostic (i.e., theragnostic) applications have emerged with MNP use, such as MRI-guided cell replacement therapy or MRI-based imaging of cancer-specific gene delivery. However, mounting evidence suggests that certain properties of nanoparticles (e.g., enhanced reactive area, ability to cross cell and tissue barriers, resistance to biodegradation) amplify their cytotoxic potential relative to molecular or bulk counterparts. Oxidative stress, a 3-tier paradigm of nanotoxicity, manifests in activation of reactive oxygen species (ROS) (tier I), followed by a proinflammatory response (tier II) and DNA damage leading to cellular apoptosis and mutagenesis (tier III). Invivo administered MNPs are quickly challenged by macrophages of the reticuloendothelial system (RES), resulting in not only neutralization of potential MNP toxicity but also reduced circulation time necessary for MNP efficacy. We discuss the role of MNP size, composition and surface chemistry in their intracellular uptake, biodistribution, macrophage recognition and cytotoxicity, and review current studies on MNP toxicity, caveats of nanotoxicity assessments and engineering strategies to optimize MNPs for biomedical use.
This paper references
10.1016/J.COPBIO.2006.11.001
Emerging concepts in molecular MRI.
D. Sosnovik (2007)
10.1186/1743-8977-3-11
The potential risks of nanomaterials: a review carried out for ECETOC
P. Borm (2006)
10.1007/978-1-4757-6482-6
Scientific and clinical applications of magnetic carriers
U. Häfeli (1997)
10.1016/0169-409X(95)00022-Y
Which polymers can make nanoparticulate drug carriers long-circulating?
V. Torchilin (1995)
10.1080/08958370600747770
When Nanoparticles Get in the Way: Impact of Projected Area on In Vivo and In Vitro Macrophage Function
O. Moss (2006)
10.1016/J.BRAINRESPROT.2005.10.004
A procedure for selecting and culturing subpopulations of neurons from rat dorsal root ganglia using magnetic beads.
B. Tucker (2005)
10.1021/ES052069I
In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility.
T. Brunner (2006)
10.1021/LA0257337
Interaction of Anionic Superparamagnetic Nanoparticles with Cells: Kinetic Analyses of Membrane Adsorption and Subsequent Internalization
C. Wilhelm (2002)
10.1126/science.310.5754.1609
Calls Rise for More Research on Toxicology of Nanomaterials
R. Service (2005)
10.1080/02656730601175479
Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial
M. Johannsen (2007)
10.1021/NL061025K
Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm.
T. Xia (2006)
10.1016/0169-409X(95)00039-A
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
G. Storm (1995)
Intracellular magnetic labeling with CLIO-Tat for efficient in vivo tracking of cytotoxic T cells by MR imaging
MF Kircher (2002)
10.1097/01.wco.0000245365.51823.72
Immune circuitry in the peripheral nervous system
B. Kieseier (2006)
10.1021/LA052710U
Fluorescence-modified superparamagnetic nanoparticles: intracellular uptake and use in cellular imaging.
F. Bertorelle (2006)
10.2217/17435889.2.1.23
Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
A. Gupta (2007)
Nanomaterial health effects--part 1: background and current knowledge.
Maria C Powell (2006)
10.1161/ATVBAHA.107.151175
p38 MAPK Inhibition Reduces Aortic Ultrasmall Superparamagnetic Iron Oxide Uptake in a Mouse Model of Atherosclerosis: MRI Assessment
J. Morris (2008)
10.1088/0022-3727/36/13/201
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2003)
10.1021/BC0255236
Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake.
M. Zhao (2002)
10.1016/J.JMMM.2003.12.852
Long-term retention of dextran-coated magnetite nanoparticles in the liver and spleen
L. M. Lacava (2004)
10.1016/j.mcn.2005.10.011
TNFα-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve
Veronica I. Shubayev (2006)
10.1021/JS980084Y
Nanoparticle technology for delivery of drugs across the blood-brain barrier.
U. Schroeder (1998)
10.1263/JBB.100.1
Medical application of functionalized magnetic nanoparticles.
A. Ito (2005)
10.1016/j.neulet.2006.07.020
Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance
Gang Liu (2006)
10.1016/S1525-0016(03)00065-0
Magnetofection--a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo.
F. Kroetz (2003)
10.1016/j.addr.2012.09.015
Nanoparticulate systems for brain delivery of drugs.
J. Kreuter (2001)
10.1016/j.biomaterials.2008.04.016
Universal cell labelling with anionic magnetic nanoparticles.
C. Wilhelm (2008)
10.1016/S0304-8853(99)00002-5
Biological effects of magnetic fluids: toxicity studies
Z. Lacava (1999)
10.1126/SCIENCE.1088755
Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins
J. Nam (2003)
10.1038/nbt872
The 'right' size in nanobiotechnology
G. Whitesides (2003)
10.1002/ADMA.200800004
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging.
J. Park (2008)
10.1002/JBM.A.31189
Acute toxicity and irritation of water-based dextran-coated magnetic fluid injected in mice.
Zhai Yu (2008)
10.1097/01.rli.0000101027.57021.28
Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10
I. Raynal (2004)
10.1126/SCIENCE.1114397
Toxic Potential of Materials at the Nanolevel
A. Nel (2006)
10.1016/J.TIV.2005.06.034
In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
S. Hussain (2005)
10.1002/JBM.A.31346
Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles.
H. Ma (2008)
10.1021/BC000079X
Improvement of MRI probes to allow efficient detection of gene expression.
D. Högemann (2000)
10.1016/j.neuroimage.2006.03.028
Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE
B. Brochet (2006)
10.1016/S1359-6446(05)03637-8
The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets.
R. Myers (2006)
10.1159/000073901
Magnetofection Potentiates Gene Delivery to Cultured Endothelial Cells
F. Kroetz (2003)
10.1038/74464
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
M. Lewin (2000)
10.1080/17435390701314761
Toxicology of nanoparticles: A historical perspective
G. Oberdoerster (2007)
10.1021/mp7001285
Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats.
Tapan Jain (2008)
10.1289/ehp.8497
Induction of Inflammation in Vascular Endothelial Cells by Metal Oxide Nanoparticles: Effect of Particle Composition
A. Gojova (2007)
10.1016/j.addr.2007.11.007
Clinical toxicities of nanocarrier systems.
K. R. Vega-Villa (2008)
10.1016/J.FREERADBIOMED.2005.03.033
Matrix metalloproteinases and free radicals in cerebral ischemia.
K. Jian Liu (2005)
10.1098/rsbl.2003.0012
Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue
D. Hautot (2003)
10.1002/JBM.A.31724
Magnetic nanoparticles for improving cell invasion in tissue engineering.
Takuro Sasaki (2008)
10.1038/nbt1201-1141
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
J. Bulte (2001)
10.1016/J.IJPHARM.2003.09.042
The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture.
C. Berry (2004)
10.1006/JSSC.2001.9117
Gold-coated iron (Fe@Au) nanoparticles: Synthesis, characterization, and magnetic field-induced self-assembly
J. Lin (2001)
10.1093/TOXSCI/KFM018
Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
C. Sayes (2007)
10.1016/J.ENVINT.2006.06.014
Do nanoparticles present ecotoxicological risks for the health of the aquatic environment?
M. Moore (2006)
10.1515/BC.2005.026
Phosphoinositide 3-kinase signaling in the cellular response to oxidative stress
A. Barthel (2005)
Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: the effect of non-ionic surfactants. Langmuir 2001;17:2900–2906
S Santra (2001)
10.1021/LA0008636
Synthesis and Characterization of Silica-Coated Iron Oxide Nanoparticles in Microemulsion: The Effect of Nonionic Surfactants
S. Santra (2001)
10.1539/joh.50.1
Body Distribution of Inhaled Fluorescent Magnetic Nanoparticles in the Mice
Jung-Taek Kwon (2008)
10.1189/jlb.0206110
Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery
S. Gorantla (2006)
10.1016/J.BIOMATERIALS.2004.05.022
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
10.1088/0022-3727/36/13/202
The preparation of magnetic nanoparticles for applications in biomedicine
P. Tartaj (2003)
10.1007/s00249-003-0312-0
Deformation of intracellular endosomes under a magnetic field
C. Wilhelm (2003)
10.1038/sj.gt.3301624
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
Friedrich Scherer (2002)
10.1038/sj.bjp.0707130
Nanoparticles: pharmacological and toxicological significance
C. Medina (2007)
10.1634/stemcells.2007-0016
Fluorophore‐Conjugated Iron Oxide Nanoparticle Labeling and Analysis of Engrafting Human Hematopoietic Stem Cells
Dustin J. Maxwell (2008)
10.2217/17435889.1.2.157
Magnetic nanoparticles and their applications in medicine.
E. Duguet (2006)
10.1016/J.MRFMMM.2004.06.015
Signal transduction pathways relevant for neoplastic effects of fibrous and non-fibrous particles.
C. Albrecht (2004)
10.1016/J.FREERADBIOMED.2004.06.008
Mitochondrial redox control of matrix metalloproteinases.
K. K. Nelson (2004)
10.1002/CHIN.200625211
Why Gold Nanoparticles Are More Precious than Pretty Gold: Noble Metal Surface Plasmon Resonance and Its Enhancement of the Radiative and Nonradiative Properties of Nanocrystals of Different Shapes
S. Eustis (2006)
Work in Brief
D. Loomis (2006)
10.1016/J.BIOMATERIALS.2005.05.044
Therapeutic potential of nanoparticulate systems for macrophage targeting.
F. Chellat (2005)
10.1080/00222930701314932
Cellular responses to nanoparticles: Target structures and mechanisms
K. Unfried (2007)
Acute toxicity of magnetic nanoparticles in mice.
A. Gajdošíková (2006)
10.1021/BC980125H
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.
L. Josephson (1999)
10.1007/978-1-4757-6482-6_28
Specific Blood Purification by Means of Antibody-Conjugated Magnetic Microspheres
C. Weber (1997)
10.1016/S0147-6513(03)00062-9
Essential metals--case study on iron.
E. Gurzău (2003)
10.1016/S0304-8853(98)00558-7
Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro
A. Jordan (1999)
10.1523/JNEUROSCI.3126-04.2004
Superparamagnetic Iron Oxide-Labeled Schwann Cells and Olfactory Ensheathing Cells Can Be Traced In Vivo by Magnetic Resonance Imaging and Retain Functional Properties after Transplantation into the CNS
M. Dunning (2004)
10.1002/mrm.20532
MRI detection of macrophage activity after experimental stroke in rats: New indicators for late appearance of vascular degradation?
R. Weber (2005)
10.1136/oem.2005.024802
The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area
Claire Monteiller (2007)
10.2174/092986705774462987
Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
M. Blanuša (2005)
10.1016/j.expneurol.2005.01.020
Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats
T. Green-Sadan (2005)
10.1517/17425255.1.4.701
Evaluation of neurotoxic potential by use of in vitro systems
G. J. Harry (2005)
10.1016/J.BIOMATERIALS.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
10.1002/JMRI.1880070629
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
A. Moore (1997)
10.1021/ES060589N
Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity.
T. Long (2006)
Nanomaterial health effects--Part 2: Uncertainties and recommendations for the future.
Maria C Powell (2006)
10.1016/S1474-4422(03)00353-3
Iron misregulation in the brain: a primary cause of neurodegenerative disorders
Y. Ke (2003)
10.1227/01.NEU.0000175731.25414.4c
Imaging, Distribution, and Toxicity of Superparamagnetic Iron Oxide Magnetic Resonance Nanoparticles in the Rat Brain and Intracerebral Tumor
L. Muldoon (2005)
10.1038/nbt0806-942
Shifting emphasis from pharmacogenomics to theragnostics
V. Ozdemir (2006)
10.1016/S0167-4889(98)00002-0
Measuring transferrin receptor gene expression by NMR imaging.
A. Moore (1998)
10.1016/J.EJPS.2005.08.002
In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size.
Chao Fang (2006)
10.1002/CHIN.200547224
Synthesis, Properties, and Applications of Iron Nanoparticles
D. Huber (2005)
10.1593/NEO.05769
Nanoparticle imaging of integrins on tumor cells.
X. Montet (2006)
10.1016/J.TIV.2006.02.004
Matrix metalloproteinases and their inhibitors as biomarkers for metal toxicity in vitro.
M. Cammarota (2006)
10.1016/S1367-5931(99)00073-3
Metals and neuroscience.
A. Bush (2000)
10.1586/17434440.3.4.427
Cellular magnetic resonance imaging: current status and future prospects
A. Arbab (2006)
10.1038/nprot.2007.352
Generation of magnetic nonviral gene transfer agents and magnetofection in vitro
O. Mykhaylyk (2007)
10.1016/S1474-4422(04)00809-9
Metals in our minds: therapeutic implications for neurodegenerative disorders
P. Doraiswamy (2004)
Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles.
K. Sokolov (2003)
10.1016/S0142-9612(01)00267-8
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake.
Y. Zhang (2002)
10.3109/02656739309061478
Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia.
A. Jordan (1993)
10.1016/J.BIOMATERIALS.2007.01.043
Nanotoxicity of iron oxide nanoparticle internalization in growing neurons.
T. R. Pisanic (2007)
10.1016/J.ADDR.2004.12.001
Tat peptide-mediated cellular delivery: back to basics.
Hilary Brooks (2005)
10.1021/CR030698+
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology.
M. Daniel (2004)
10.1016/S0301-0082(98)00083-5
The role of microglia and macrophages in the pathophysiology of the CNS
Guido Stollg (1999)
10.1161/01.STR.0000250048.42916.ad
Imaging Inflammation in Acute Brain Ischemia
S. Jander (2007)
10.1038/73219
In vivo magnetic resonance imaging of transgene expression
R. Weissleder (2000)
10.1038/nrm2125
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw (2007)
10.1021/BI00457A029
Deformation and instability in membrane structure of phospholipid vesicles caused by osmophobic association: mechanical stress model for the mechanism of poly(ethylene glycol)-induced membrane fusion.
M. Yamazaki (1990)
10.1152/AJPLUNG.00139.2003
Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles.
D. Brown (2004)
10.1093/TOXSCI/KFJ027
Toxicity and tissue distribution of magnetic nanoparticles in mice.
J. Kim (2006)
10.1021/NL060177C
Oops they did it again! Carbon nanotubes hoax scientists in viability assays.
J. M. Wörle-Knirsch (2006)
10.1016/J.BIOMATERIALS.2003.12.058
Strong and bioactive composites containing nano-silica-fused whiskers for bone repair.
H. Xu (2004)
In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.
M. Kircher (2003)
10.1002/JPS.2600710716
Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles.
B. Kante (1982)
10.1038/sj.cgt.7700357
Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy
A. Ito (2001)
10.1080/10934520600966177
Toxicity of Metal Oxide Nanoparticles in Mammalian Cells
H. Jeng (2006)
Strain-mediated electric-field control of resistance in the La[sub 0.85]Sr[sub 0.15]MnO₃/0.7Pb(Mg[sub ⅓]Nb[sub ⅔])O₃-0.3PbTiO₃ structure
R. Zheng (2007)
10.1002/mrm.10418
Cell internalization of anionic maghemite nanoparticles: Quantitative effect on magnetic resonance imaging
C. Billotey (2003)
10.1063/1.2711522
Self-assembled magnetic nanowire arrays
J. Lagdani (2006)
10.1080/02713680600813854
Biocompatibility of Polyvinylalcohol Gel as a Vitreous Substitute
S. Maruoka (1998)
10.1902/JOP.2006.050064
Phenotypic study of human gingival fibroblasts labeled with superparamagnetic anionic nanoparticles.
A. Naveau (2006)
10.1063/1.1599959
Static and dynamic magnetic properties of spherical magnetite nanoparticles
G. F. Goya (2003)
10.1002/glia.10108
Matrix metalloproteinases in neuroinflammation
G. Rosenberg (2002)
Matrix metalloproteinases and free radicals in cerebral ischemia
K JianLiu (2005)
10.1080/17435390701314902
Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies
K. Powers (2007)
10.1038/sj.gt.3302720
Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery
J. Dobson (2006)
10.1016/S0142-9612(02)00440-4
Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating.
C. Wilhelm (2003)
10.1016/J.ATHEROSCLEROSIS.2006.08.048
Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques.
C. von zur Muhlen (2007)
10.1093/TOXSCI/KFL165
Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments.
J. Teeguarden (2007)
10.2217/17435889.2.2.153
Targeted delivery of multifunctional magnetic nanoparticles.
J. Mccarthy (2007)
10.1016/J.BBADIS.2006.09.011
Preliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patients.
D. Hautot (2007)
10.1080/10408440601177780
Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety
G. Nohynek (2007)
10.1002/1521-4095(200111)13:21<1620::AID-ADMA1620>3.0.CO;2-Z
Single‐Step Nanoengineering of Silica Coated Maghemite Hollow Spheres with Tunable Magnetic Properties
P. Tartaj (2001)
10.1007/s00249-001-0200-4
Magnetophoresis and ferromagnetic resonance of magnetically labeled cells
C. Wilhelm (2002)
10.1002/ANIE.200602866
Magnetic nanoparticles: synthesis, protection, functionalization, and application.
A. Lu (2007)
10.1023/B:JMSM.0000021126.32934.20
Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture
A. Gupta (2004)
10.1177/039463200702000404
Metallic Nanoparticles Exhibit Paradoxical Effects on Oxidative Stress and Pro-Inflammatory Response in Endothelial Cells in Vitro
K. Peters (2007)
10.1289/ehp.7339
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
G. Oberdörster (2005)
10.1136/oem.2003.008227
Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types
L. Renwick (2004)
10.1080/08958370701353080
Testing Strategies to Establish the Safety of Nanomaterials: Conclusions of an ECETOC Workshop
D. Warheit (2007)
Functionalisation of magnetic nanoparticles for applications in biomedicine : Biomedical applications of magnetic nanoparticles
C. Berry (2003)
10.1186/1743-8977-2-8
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
G. Oberdörster (2005)
10.1093/TOXSCI/KFM169
Nanotechnology safety concerns revisited.
S. Stern (2008)
10.1038/SJ.JID.5700733
Penetration of metallic nanoparticles in human full-thickness skin.
B. Baroli (2007)
10.1063/1.1555312
Gold-coated iron nanoparticles for biomedical applications
M. Chen (2003)
10.1038/nnano.2007.223
Immunological properties of engineered nanomaterials
M. Dobrovolskaia (2007)



This paper is referenced by
10.1016/j.addr.2016.08.012
Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))-poly(ethylene glycol) nanotechnology as a model: An industrial viewpoint.
H. R. Lakkireddy (2016)
10.18452/16445
Biodegradierbare Nanopartikel als Transportsysteme für Wirkstoffe in der Photodynamischen Therapie
A. Preuß (2012)
10.2217/nnm.10.114
Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications.
Reynolds A. Frimpong (2010)
10.1517/17425247.2012.652614
Production methodologies of polymeric and hydrogel particles for drug delivery applications
A. C. Lima (2012)
10.2174/1568009611313040002
Nanomedicines as cancer therapeutics: current status.
S. Akhter (2013)
Application of Glycoconjugate-Functionalized Magnetic Nanoparticles as Potent Anti-Adhesion and Anti-Bacterial Agents
Y. Raval (2017)
10.1016/J.CPLETT.2012.04.063
Preparation and characterization of CS–Fe3O4@ZnS:Mn magnetic-fluorescent nanoparticles in aqueous media
L. Liu (2012)
10.1088/0957-4484/21/45/455102
Aptamer conjugated magnetic nanoparticles as nanosurgeons.
B. G. Nair (2010)
10.1002/9781119241966.CH5
Magnetic Nanomaterial-based Anticancer Therapy
Catalano Enrico (2016)
10.1021/acsnano.7b06734
Fucoidan Prolongs the Circulation Time of Dextran-Coated Iron Oxide Nanoparticles.
M. Abdollah (2018)
10.1371/journal.pone.0069812
Enhanced Nanomagnetic Gene Transfection of Human Prenatal Cardiac Progenitor Cells and Adult Cardiomyocytes
M. Subramanian (2013)
10.3892/mmr.2017.7994
Advances in the T7 phage display system (Review).
Xiangying Deng (2018)
10.1039/c0an00221f
Magnetic bead-based fluorescence immunoassay for aflatoxin B1 in food using biofunctionalized rhodamine B-doped silica nanoparticles.
D. Tang (2010)
10.4155/tde.11.81
Phase-shift, stimuli-responsive drug carriers for targeted delivery.
B. E. O’Neill (2011)
10.1016/j.biomaterials.2019.04.023
Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy.
Xiaoqin Qian (2019)
10.2174/0929867326666190104164653
Glycan Carriers As Glycotools For Medicinal Chemistry Applications.
M. Vacchini (2019)
10.1016/j.fct.2012.07.005
Toxicological effects of cationic nanobubbles on the liver and kidneys: biomarkers for predicting the risk.
T. Pan (2012)
10.1155/2015/797606
Photodegradation of Eosin Y Using Silver-Doped Magnetic Nanoparticles
Eman Alzahrani (2015)
10.1039/C5RA03331D
Magnetite/dextran-functionalized graphene oxide nanosheets for in vivo positive contrast magnetic resonance imaging
Shahab Moradi (2015)
10.1088/1757-899X/305/1/012012
Size-dependent magnetic anisotropy of PEG coated Fe3O4 nanoparticles; comparing two magnetization methods
C. Nayek (2018)
10.1002/PPSC.201700486
Fabrication of Magnetically Stirrable Anisotropic Microparticles via the Microfluidic Method
M. Xia (2018)
10.1016/J.CEJ.2014.08.024
Facile synthesis and biological assessment of conjugated linolenic acid-modified, bovine serum albumin-linked, magnetic γ-Fe2O3 nano-composites
L. Wang (2015)
10.1016/J.SUPFLU.2011.10.019
Synthesis of shape-controlled and organic-hybridized hafnium oxide nanoparticles under sub- and supercritical hydrothermal conditions
Ameneh Sahraneshin (2012)
10.2217/NNM.14.5
Bench-to-bedside translation of magnetic nanoparticles.
D. Singh (2014)
10.1021/ACS.CHEMMATER.6B03905
Cellular Organelle-Dependent Cytotoxicity of Iron Oxide Nanoparticles and Its Implications for Cancer Diagnosis and Treatment: A Mechanistic Investigation
Chieh-Cheng Huang (2016)
10.1039/C3RA46914J
Synthesis and characterization of S-PCL-PDMAEMA for co-delivery of pDNA and DOX
Yu-Lun Lo (2014)
10.1016/j.msec.2013.07.012
Contrast agents for MRI.
H. Shokrollahi (2013)
Physicochemical and antibacterial properties of cotton fabric treated with chitosan-tripolyphosphate nanoparticles and lauric acid
Siti Nur Hana Mamat (2016)
10.1371/journal.pone.0040388
A Novel Magnetic Nanoparticle Drug Carrier for Enhanced Cancer Chemotherapy
X. Chao (2012)
10.1007/S11051-010-0019-Y
Systematic evaluation of biocompatibility of magnetic Fe3O4 nanoparticles with six different mammalian cell lines
Yingxun Liu (2011)
10.1002/ADFM.201202898
Functionalized Fe-filled multiwalled carbon nanotubes as multifunctional scaffolds for magnetization of cancer cells
Riccardo Marega (2013)
10.4155/TDE.11.12
Nucleic acid delivery using magnetic nanoparticles: the Magnetofection technology.
Nicolas Laurentt (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar